Current page location

Industrial Bio-meterial Research Center

Industrial Bio-meterial Research Center
Objectives
Secure origin base and commercial technology which can be used in relevant fields by developing industrial biomaterials, high efficient enzyme, functional food, food and drug and biological agent from various biological resources (insects, microorganism, marine organisms, plants, etc.) in nature.
  • Development of high efficient and industrial enzyme derived from insects
  • Development of functional materials of health functional foods and nutraceuticals related to metabolic disease, cirrhosis, and liver cancer
  • Development of biological agent derived from natural substances
  • Studies on technology business through using bio-diversity
Researchers
    Click on the name
researchers and research statement
name research fields
Kwang-Hee Son
/ Associate Director
  • Microbial Biotechnology
  • Bio-diversity based enzymes for industrial uses
  • Microbial natural products for pharmaceutical uses
Ho-Yong Park
/ Principal Researcher
  • Highly active enzymes and bio-materials from invertebrates & microbes for industrial application
  • Development of bio-insecticides for the control of agricultural insects by insect pathogens
Tae-Sook Jeong
/ Principal Researcher
  • Screening, in vivo efficacy test, and mechanism study of bioactive materials for prevention and treatment of metabolic syndrome (including obesity, diabetes, hyperlipidemia, and atherosclerosis) and using them for the development of functional foods and nutraceuticals
Chang-Jin Kim
/ Principal Researcher
  • Management of actinobacteria
  • Microbial diversity and biocontrol agents
Kee-Sun Shin
/ Principal Researcher
  • Yeast systematics and phylogeny
Do Young Kim
/ Senior Researcher
  • Development of multi-functional fibrolytic enzymes with unique properties from invertebrate-symbiotic bacteria
  • Analysis of microbial genomes and development of various bio-based materials (biocatalysts, biopolymers, etc.)
Dong Jin Park
/ Principal Technician
  • Management and preservaion of actinobacteria, screening of functional compounds
research areas
  • Development of biodiversity based biological materials using convergence technology
    • Development of high functional enzyme and biological materials from in living things such as insects, microorganism, etc. in various environments
    • Development of biological catalyst for bioenergy production to use non-biodegradable biomass
    • Development of green biological agent using insect pathogenicity organism
  • Development of antiviral agent for hepatitis treatment caused by HBV
    • Separation of three types of antivirus agents from domestic native plants
    • It is found that three types of antivirus agents can prevent drug tolerance caused by mutation seen commonly during antiviral agent treatment because separated three types of antivirus agents are applied respectively to different part during life cycle of HBV.
  • Development of base technology for preventing and treating metabolic disease
    • Investigation of causes of metabolic disease and Finding targets for treatment
    • Finding bioactive substance for preventing and treating metabolic disease and Development of health functional foods or nutraceuticals
  • Development of biological material inhibiting microorganism function from natural resource
    • Search and development of inhibitor of type III secretion system causing pathogenicity of grammegative bacterium
    • Search and development of new biological material showing inhibitory activity in plant pathogenic eumycetes
Achievements
  • Development of high efficient protease and Arazyme
    • The Center developed high efficient protease and Arazyme which have a relatively very high vitality in various environmental conditions from intestinal microorganism of Korean silk spider. Products such as feed additives, functional cosmetics, foods, raw material medicine, detergent, and leather processing agents, etc. which use Arazyme succeeded in its commercialization through relevant application development study and technology transfer are receiving huge attention and sold in domestic and overseas market.
    • The Center has involved in the preliminary work. Korea which takes in charge of the second chromosome accounting for 12% of total genome has achieved about progress rate of 60%. The Center hopes these activities gives a golden opportunity to internationally vitalize plant biotechnology industry in Korea.
  • Development of functional materials from soy leaf extracts for prevention and treatment of obesity and diabetes and Investigation of their action mechanism